Therefore, more precise and sophisticated studies, for example, by employing CRISPR/Cas9 genome editing approach to establish either p200 CUX1 unprocessable or p200 CUX1 null mutants, are required to define the roles of p200 CUX1 and its isoforms in tumor development. This evidence concerns the gene CUX1 and neoplasm.